Navigation Links
Dr. Lester Mandelker to Collaborate with Nuovo Biologics, LLC
Date:8/17/2011

MIAMI, Aug. 17, 2011 /PRNewswire/ -- Nuovo Biologics, LLC has announced a collaboration with Dr. Lester Mandelker a Largo, Florida veterinarian. Dr. Mandelker will supervise all small non consumable animal veterinary related activities implemented by the Company in its pursuit of FDA/CVM NADA approvals for Panavira™ including (but not limited to) respiratory disease caused by viral infections, canine malignant melanoma, feline leukemia (FeLv) and feline immune deficiency (FIU).

Dr. Mandelker will assist the company in developing a veterinary research organization designed to train veterinarians to perform and manage clinical research.  Dr. Mandelker will help recruit both his own patients and other qualified veterinarians to bring their patients to participate in the pilot and field studies for Panavira™ and other veterinary products.

Dr. Mandelker who maintains active memberships in AVMA, FVMA, AAHA, FVMA, ABVP and the FAAVPT has been in private practice since 1972 at the Community Veterinary Hospital, in Largo Florida, which is an AAHA Certified Hospital.

Over the last several decades Dr. Mandelker has maintained a high degree of peer respect and acknowledgement. A Past President of the Pinellas County (Florida) Veterinary Medical Association, he was selected among the nation's top veterinarians in 2006 & 2007 by the Consumer's Research Council of America and was Chairman of Examination Committee of the American Board of Veterinary Practitioners from 1900 to 1992.

Dr. Mandelker is a Diplomat of The American Board of Veterinary Practitioners and is certified in Canine and Feline Medicine.  His Specialty Interest is Pharmacology, Nutraceuticals and Antioxidants. Dr. Mandelker is also a Fellow of the American Academy of Pharmacology and Therapeutics (FAAVPT).

Dr. Mandelker has published over 175 scientific articles on pharmacology, medicine and nutraceuticals in journals such as: AVMA journal, VM/SAC, Veterinary Forum and The Veterinary Clinics of North America.  He has done extensive work in pharmacology and first introduced various human pharmacological agents to veterinary medicine and is in demand as a speaker on Veterinary Pharmacology.

Nuovo Biologics is a Florida based animal health company dedicated to the development of innovative, safe and efficacious drugs, biologicals and supplements that enhance animal health and wellness.


'/>"/>
SOURCE Nuovo Biologics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Amsterdam Molecular Therapeutics Successfully Lowers Cholesterol In Vivo With Enhanced Novel MicroRNA AAV Gene Therapy
2. Expanded Lipoprotein Testing, VAP® Cholesterol Test Discussed at National Lipid Association Summer Clinical Lipid Update
3. Atherotech Emphasizes Predictive Value of VAP(R) Cholesterol Test at National Lipid Association Meeting
4. Santaris Pharma A/S Advances RNA-Targeted Drug Development Candidate Against PCSK9, an Important New Target for the Treatment of High Cholesterol
5. Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers
6. New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol
7. VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R)
8. Atherotech to Exhibit its VAP(R) Cholesterol Test at Internal Medicine 2009 in Philadelphia
9. First Application to Fight High Cholesterol Launches on the iPhone and iPod Touch
10. Atherotech to Exhibit the VAP(R) Cholesterol Test at ACC.09 in Orlando
11. VAP Cholesterol Test Helps In Search For New Heart Disease Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec 5, 2016 Research ... report "DNA Sequencing - Technologies, Markets and Companies" ... ... report briefly reviews basics of human genome variations, development of ... are described as well as companies developing them. Various applications ...
(Date:12/4/2016)... , Dec. 3, 2016  In five studies ... Hematology (ASH) Annual Meeting and Exposition in ... engineering methods to improve the delivery of life-saving treatments ... new methods are designed to carry therapies directly to ... most, which could provide a substantial advantage over traditional, ...
(Date:12/2/2016)... 2016  The Multiple Myeloma Research Foundation (MMRF) today ... Study SM —the largest and most comprehensive study driving ... myeloma—will be presented at the 58 th American ... San Diego from December 3-6. ... as well as identify pathways and targets for new ...
(Date:12/2/2016)... ... ... ACEA Biosciences, Inc. announced today that it will be presenting updated efficacy ... Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. , ... AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR T790M resistance ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
Breaking Biology News(10 mins):